%0 Journal Article
%T Assessment of Dual Life Stage Antiplasmodial Activity of British Seaweeds
%A Jasmine Spavieri
%A Andrea Allmendinger
%A Marcel Kaiser
%A Maurice Ayamba Itoe
%A Gerald Blunden
%A Maria M. Mota
%A Deniz Tasdemir
%J Marine Drugs
%D 2013
%I MDPI AG
%R 10.3390/md11104019
%X Terrestrial plants have proven to be a prolific producer of clinically effective antimalarial drugs, but the antimalarial potential of seaweeds has been little explored. The main aim of this study was to assess the in vitro chemotherapeutical and prophylactic potential of the extracts of twenty-three seaweeds collected from the south coast of England against blood stage (BS) and liver stage (LS) Plasmodium parasites. The majority (14) of the extracts were active against BS of P. falciparum, with brown seaweeds Cystoseira tamariscifolia, C. baccata and the green seaweed Ulva lactuca being the most active (IC 50s around 3 ¦Ìg/mL). The extracts generally had high selectivity indices (>10). Eight seaweed extracts inhibited the growth of LS parasites of P. berghei without any obvious effect on the viability of the human hepatoma (Huh7) cells, and the highest potential was exerted by U. lactuca and red seaweeds Ceramium virgatum and Halopitys incurvus (IC 50 values 14.9 to 28.8 ¦Ìg/mL). The LS-active extracts inhibited one or more key enzymes of the malarial type-II fatty acid biosynthesis (FAS-II) pathway, a drug target specific for LS. Except for the red seaweed Halopitys incurvus, all LS-active extracts showed dual activity versus both malarial intracellular stage parasites. This is the first report of LS antiplasmodial activity and dual stage inhibitory potential of seaweeds.
%K seaweed
%K marine alga
%K malaria
%K Plasmodium
%K malaria prophylaxis
%K fatty acid biosynthesis
%K liver stage
%K blood stage
%U http://www.mdpi.com/1660-3397/11/10/4019